(19)
(11) EP 0 985 679 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.09.2003 Bulletin 2003/36

(45) Mention of the grant of the patent:
23.04.2003 Bulletin 2003/17

(21) Application number: 99117654.6

(22) Date of filing: 07.09.1999
(51) International Patent Classification (IPC)7: C07H 17/08

(54)

New hydroxy derivatives of tylosin and process for their preparation

Neue Hydroxyderivate von Tylosin und Verfahren zu deren Herstellung

Nouveaux dérivés hydroxy du tylosine et procédé pour leur preparation

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
MK RO SI

(30) Priority: 10.09.1998 HR 980496

(43) Date of publication of application:
15.03.2000 Bulletin 2000/11

(73) Proprietor: PLIVA farmaceutska industrija, dionicko drustvo
10000 Zagreb (HR)

(72) Inventors:
  • Narandja, Amalija
    10000 Zagreb (HR)
  • Lopotar, Nevenka
    10000 Zagreb (HR)
  • Mandic, Zoran
    10000 Zagreb (HR)

(74) Representative: von Füner, Nicolai, Dr. et al
v. Füner Ebbinghaus Finck Hano Patentanwälte Postfach 95 01 60
81517 München
81517 München (DE)


(56) References cited: : 
EP-A- 0 100 645
EP-A- 0 287 082
 EP-A- 0 134 054
EP-A- 0 839 827
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).